-
Recent guidance from the United States Preventive Services Task Force has affirmed the evidence-based value of screening male current/ex-smokers older than age 65 for abdominal aortic aneurysm.
-
The FDA has approved the combination of isosorbide dinitrate and hydralazine for the treatment of heart failure in the black (African decent) population.
-
Understanding of etiologies, management, and outcomes of febrile neutropenia has improved in recent years, and it is now possible to identify patients at high risk for morbidity and mortality using demographic, historical, and laboratory indicators.
-
When closest family members of critically ill patients were interviewed 90 days later, significant post-traumatic stress symptoms were present in one-third of them. Risks for PTSD were more prevalent if the patient had died in the ICU, especially after end-of-life decision-making in which the family member participated.
-
When the Women’s Health Initiative (WHI) study was stopped, 9351 postmenopausal women stopped taking combined estrogen and progestin or placebo. The WHI investigators followed up on these women with a survey at 8 to 12 months after stopping the pills. More that half of the women taking the hormones developed vasomotor symptoms and, in about 21%, these symptoms were moderate to severe.
-
Seven pieces of information can identify those patients most likely to successfully rehabilitate back pain.
-
-
Chocolate enthusiasts, take heart! Evidence that dark chocolate benefits more than just the palate is presented in this study from Greece.
-
The FDA has approved a new long-acting insulin analog produced by DNA technology.
-
Breast cancer in young women is uncommon, but when it does occur, it is thought to be very aggressive. In this large series of young (< 35 years old) patients from a single institution seen over a 13-year period, high tumor grade, hormone receptor negativity, and family history of ovarian cancer turned out to be significant negative prognostic indicators.